172 related articles for article (PubMed ID: 30398879)
21. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases.
Lee J; Banu SK; Subbarao T; Starzinski-Powitz A; Arosh JA
Mol Cell Endocrinol; 2011 Jan; 332(1-2):306-13. PubMed ID: 21111772
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.
Ganesh T
Expert Opin Ther Pat; 2015 Jul; 25(7):837-44. PubMed ID: 25772215
[TBL] [Abstract][Full Text] [Related]
24. Prostanoid receptor EP2 as a therapeutic target.
Ganesh T
J Med Chem; 2014 Jun; 57(11):4454-65. PubMed ID: 24279689
[TBL] [Abstract][Full Text] [Related]
25. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
Hayashi Y; Morinaga S; Liu X; Zhang J; Wu Z; Yokoyama T; Nakanishi H
Mediators Inflamm; 2016; 2016():5079597. PubMed ID: 27298516
[TBL] [Abstract][Full Text] [Related]
26. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
Jiang J; Yu Y; Kinjo ER; Du Y; Nguyen HP; Dingledine R
Neuropharmacology; 2019 May; 149():149-160. PubMed ID: 30763657
[TBL] [Abstract][Full Text] [Related]
27. Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis.
Arosh JA; Sivakumar KK; Lee J; Banu SK
Mol Cell Endocrinol; 2022 Dec; 558():111728. PubMed ID: 35944745
[TBL] [Abstract][Full Text] [Related]
28. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
[TBL] [Abstract][Full Text] [Related]
29. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway.
Olesen ET; Moeller HB; Assentoft M; MacAulay N; Fenton RA
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F935-F944. PubMed ID: 27558562
[TBL] [Abstract][Full Text] [Related]
30. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.
Sluter MN; Hou R; Li L; Yasmen N; Yu Y; Liu J; Jiang J
J Med Chem; 2021 Aug; 64(16):11816-11836. PubMed ID: 34352171
[TBL] [Abstract][Full Text] [Related]
31. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
32. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 blockade enhances the pulmonary anti-Cryptococcus neoformans immune reaction via the induction of TLR-4.
Shen L; Liu Y
Int Immunopharmacol; 2015 Sep; 28(1):376-81. PubMed ID: 26122137
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
36. PGE
Liu Q; Liang X; Wang Q; Wilson EN; Lam R; Wang J; Kong W; Tsai C; Pan T; Larkin PB; Shamloo M; Andreasson KI
Proc Natl Acad Sci U S A; 2019 May; 116(20):10019-10024. PubMed ID: 31036664
[TBL] [Abstract][Full Text] [Related]
37. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
[TBL] [Abstract][Full Text] [Related]
38. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S
Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280
[TBL] [Abstract][Full Text] [Related]
40. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
